Compare CHE & MIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CHE | MIR |
|---|---|---|
| Founded | 1970 | 2005 |
| Country | United States | United States |
| Employees | N/A | 3281 |
| Industry | Medical/Nursing Services | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6B | 4.6B |
| IPO Year | 1994 | N/A |
| Metric | CHE | MIR |
|---|---|---|
| Price | $368.43 | $17.94 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 8 |
| Target Price | ★ $498.00 | $27.25 |
| AVG Volume (30 Days) | 282.3K | ★ 3.2M |
| Earning Date | 04-22-2026 | 04-28-2026 |
| Dividend Yield | ★ 0.65% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 18.34 | N/A |
| Revenue | ★ $2,529,978,000.00 | N/A |
| Revenue This Year | $6.60 | $24.16 |
| Revenue Next Year | $6.15 | $7.31 |
| P/E Ratio | ★ $20.26 | $195.00 |
| Revenue Growth | ★ 4.06 | N/A |
| 52 Week Low | $368.44 | $12.00 |
| 52 Week High | $623.61 | $30.28 |
| Indicator | CHE | MIR |
|---|---|---|
| Relative Strength Index (RSI) | 25.08 | 33.69 |
| Support Level | N/A | N/A |
| Resistance Level | $458.07 | $22.23 |
| Average True Range (ATR) | 8.82 | 1.04 |
| MACD | -1.58 | -0.07 |
| Stochastic Oscillator | 6.19 | 4.05 |
Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. The company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.